ClinicalTrials.gg

Afferent Pharmaceuticals, Inc. clinical trials

Acquired by Merck & Co., Inc, Jul 26, 2016 · source ↗

The registry lists 15 studies whose lead sponsor is Afferent Pharmaceuticals, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 22, 2022.

Before and after it joined Merck & Co., Inc

First submitted before Afferent Pharmaceuticals, Inc. became part of Merck & Co., Inc
15
First submitted after Afferent Pharmaceuticals, Inc. became part of Merck & Co., Inc
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Afferent Pharmaceuticals, Inc.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.

Studies, none open

All 15 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed1493%
  • Stopped early17%

Phase

  • Phase 211
  • Phase 14

Where

  • United States6
  • United Kingdom2

Over the years

  1. 11
  2. 12
  3. 13
  4. 14
  5. 915
  6. 16
  7. 17
  8. 18
  9. 19
  10. 20
  11. 21
  12. 22
  13. 23
  14. 24
  15. 25
  16. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)15 studies

Something wrong with this grouping? Tell us on the Merck & Co., Inc page.

Studies

Recruiting first, then most recently updated. Showing 15 of 15. All Merck & Co., Inc studies →